Financial Times: GSK’s HIV unit secures biggest ever tender in sub-Saharan Africa
“GlaxoSmithKline’s HIV drugs business, ViiV Healthcare, has secured its biggest ever tender in sub-Saharan Africa that will see its dolutegravir treatment made available to people living with the virus through a national health program for the first time…” (6/3).

Reuters: Botswana gets GSK’s modern HIV drug in largest-ever Africa tender
“…Campaign groups like Médecins Sans Frontières have been pushing for the new drug to be offered to people in developing countries since it was first approved in the United States in 2013, as the drug is well tolerated and extremely effective. No financial details were given of the contract between ViiV and the Ministry of Health in Botswana, and a GSK spokesman declined comment on price…” (Hirschler, 6/3).